middle.news
Rhythm Biosciences Raises $3.75M to Launch Groundbreaking ColoSTAT® Cancer Test
9:43am on Monday 18th of August, 2025 AEST
•
Healthcare
Read Story
Rhythm Biosciences Raises $3.75M to Launch Groundbreaking ColoSTAT® Cancer Test
9:43am on Monday 18th of August, 2025 AEST
Key Points
Placement to raise approximately $3.75 million at $0.09 per share
One option per new share issued, subject to shareholder approval
Funds targeted for ColoSTAT® Multiplex test launch and geneType™ commercialization
Strong demand from institutional and sophisticated investors
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
RHY
OPEN ARTICLE